Sangon Biotech: difference between revisions

Diff·revision 15 → 16·19:20, 13 Jul 2025

Difference between revision 15 and revision 16 of Sangon Biotech. 5 lines changed; the page grew by 873 bytes.

Revision 15 — 19:17, 20 Jun 2025 EndotoxinEd (talk) correct the trading name — the short code and the legal name are different things 8,781 bytes +389	Revision 16 — 19:20, 13 Jul 2025 BlindSampleBrid (talk) state which lines are held in regional stock 9,654 bytes +873
69	'''To obtain the batch record''', quote the lot identifier and ask for the specification sheet as well as the certificate. On the reagent lines the specification is the more informative document, because it states what the result was measured against.	69	'''To obtain the batch record''', quote the lot identifier and ask for the specification sheet as well as the certificate. On the reagent lines the specification is the more informative document, because it states what the result was measured against.
70		70
+		71	'''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.
+		72
+		73	== Reception ==
+		74	The PeptidePedia tally records 751 self-reported submissions to July 2026. Recurring themes are catalogue breadth and the documentary standard of the laboratory-reagent lines, which submissions describe as following the conventions of the reagent trade rather than those of the research-compound trade.{{r\|tally}} Self-selected; reception rather than quality.{{r\|tally}}
+		75
71	== References ==	76	== References ==
72	{{reflist}}	77	{{reflist}}